CNR2 and cancer: Cannabinoids showed promising results in treating both inflammations (which could cause cancer, such as ulcerative colitis and other inflammatory bowel diseases) and cancer-induced inflammation (Bereketoğlu 2020). Study found that CB1 and CB2 agonists administration reduced the mice-colon inflammation, cellular infiltration subsided and the epithelium returned to the normal appearance (Wardill et al. 2023).